Five-fraction stereotactic radiosurgery (SRS) for single inoperable high-risk non-small cell lung cancer (NSCLC) brain metastases

[1]  L. Trodella,et al.  Fractionated stereotactic radiosurgery for patients with brain metastases , 2014, Journal of Neuro-Oncology.

[2]  Yoshiyuki Suzuki,et al.  Five-fraction CyberKnife radiotherapy for large brain metastases in critical areas: impact on the surrounding brain volumes circumscribed with a single dose equivalent of 14 Gy (V14) to avoid radiation necrosis , 2013, Journal of radiation research.

[3]  Jacob G. Scott,et al.  Whole brain radiotherapy for brain metastasis , 2013, Surgical neurology international.

[4]  E. Oermann,et al.  Stereotactic radiosurgery for single brain metastases from non-small cell lung cancer: progression of extracranial disease correlates with distant intracranial failure , 2013, Radiation oncology.

[5]  O. Chinot,et al.  Recent trends in epidemiology of brain metastases: an overview. , 2012, Anticancer research.

[6]  M. Ogura,et al.  Outcomes of hypofractionated stereotactic radiotherapy for metastatic brain tumors with high risk factors , 2012, Journal of Neuro-Oncology.

[7]  E. Fokas,et al.  Stereotactic radiosurgery and fractionated stereotactic radiotherapy: comparison of efficacy and toxicity in 260 patients with brain metastases , 2012, Journal of Neuro-Oncology.

[8]  J. Yi,et al.  Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters , 2012, Radiation oncology.

[9]  A. Bozzao,et al.  Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis , 2011, Radiation oncology.

[10]  M. Taphoorn,et al.  Dose-effect relation in stereotactic radiotherapy for brain metastases. A systematic review. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  H. Min,et al.  Single-dose versus fractionated stereotactic radiotherapy for brain metastases. , 2010, International journal of radiation oncology, biology, physics.

[12]  Brian Wang,et al.  Hypofractionated stereotactic radiotherapy for the treatment of brain metastases , 2009, Cancer.

[13]  O. Ganslandt,et al.  Hypofractionated stereotactic radiotherapy for brain metastases--results from three different dose concepts. , 2007, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[14]  J. Roeske,et al.  Predictors of Tumor Control in Patients Treated With Linac-Based Stereotactic Radiosurgery for Metastatic Disease to the Brain , 2005, American journal of clinical oncology.

[15]  R. Onimaru,et al.  Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull. , 2003, International journal of radiation oncology, biology, physics.

[16]  R. Liščák,et al.  Solitary brain metastases treated with the Leksell gamma knife: prognostic factors for patients. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  L Souhami,et al.  Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. , 2000, International journal of radiation oncology, biology, physics.

[18]  P. Kehrli,et al.  [Epidemiology of brain metastases]. , 1999, Neuro-Chirurgie.

[19]  Susan M. Chang,et al.  Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control. , 1997, International journal of radiation oncology, biology, physics.